Tag: ANGI

Blue Horseshoe Stocks: Bottom Play Alert, HEB & More

FBC Holdings, Inc. FBCD

We wanted send out an alert on FBCD this morning, if for no other reason than the fact that it’s been quite awhile since we found a bottom play trading near all-time lows in the super-subpenny range. We’ve definitely been known to do some bottom-fishing in our day, with some of our biggest wins coming from bargain shopping.

What we have in FBCD is a stock that has been beaten back to a record low of .0005 (reached yesterday) which catches our attention in a big way. We are going to stay vigilant as we monitor this play for a solid bottom, because a snapback to to the double-zero range is not only very possible, but also has the potential to happen quite rapidly.

With so little room to the downside, one might classify FBCD as a “lottery ticket” type of play. The action on super-subpennies have the potential to return exponential gains, which is why we’re going to give it a spot on our running watchlist.

A quick glance at the chart shows that each time an influx of volume has come into the stock, it makes a run to test its 50DMA. From present levels, a jump to the current 50DMA would mean a chance for gains of at least 66%

Hemishperx BioPharma, Inc. HEB

We were passively tracking HEB via our extended watchlist last month, and are going to keep giving it our attention as the new quarter kicks off today. The stock is gapping up to the tune of roughly 25% in the premarket.

We caught notice of HEB following the company’s announcement that it would collaborate with US Army Medical Research to develop treatments to attempt to overcome the emergence of drug resistance due to Ebola virus mutation.

With the current Ebola breakout making it a hot-button topic, and the company stating this week that it would be expanding its Ebola research, we’re going to still be keeping our ears to the ground on this one.

Spherix, Inc. SPEX

SPEX made an appearance in yesterday morning’s extended watchlist and had one heck of a solid session. The stock came out of the gate and ran from a low of .99 all the way up to 1.58, offering us the chance to bank up to 60% in profits as it traded more than 13.5X its 3-month average volume.

Disappointment over the delay of some upcoming litigation that Shperix has against VTech and Uniden (View PR) is the apparent cause of the stock’s gapping down in today’s premarket.

Extended Watchlist:
LAKE, BCRX, ANGI, RVP, NNVC, CGA

Blue Horseshoe Stocks: MNKD, ANGI & Extended Watchlist

MannKind Corp. MNKD
–
In putting MNKD on bottom-watch in Friday’s Report, we gave folks the chance to catch this play at a subsequent low of 3.85 on Monday.

We were then hit with the news concerning recommendation from an FDA advisory panel to green-light one of the company’s drugs, after hours on Monday which led to a significant gap-up yesterday.

It appears as if the stock will gap up for the second consecutive session today. In pre-market trading thus far, MNKD has pushed into the 7.30’s. From the low we saw just a couple of days ago to this morning’s high (7.33), represents an overall increase of 90%

Angie’s List, Inc. ANGI

Speaking of recovery plays, ANGI is coming off of a recent bottom, and the resurgence of the share price is opening up some avenues of opportunity with regard to the options chain.

Currently on our radar are the 05/17 $15 Calls, which closed at .65 yesterday, and the 04/19 $12.50 Calls, which last traded at 1.03.

A quick look at the 6-month ANGI chart reveals a stock with the ability to make big swings. We can see that from December through January it ran from the $12-range to the $19-range with ferocity. It would appear as if we are catching it at the beginning of another swing. The RSI is rising sharply, and we’ve got a confirmed uptrend off of that bottom with higher lows and higher highs having been achieved over the past three sessions.

The potential for gains, not only with the options, but also on the stock side of things, is something that we’ll be looking for as we track ANGI during its recovery.

Extended Watchlist:
GLGT, TFER, AMRS, RGDX, ANTH,